Cypherpunk Technologies Inc. (NASDAQ:CYPH) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Augustine Lawlor Other companies: PRF Technologies Ltd. (Director · Since at least Mar 18, 2026); Gyre Therapeutics, Inc. (Director · Aug 20, 2015 – Aug 31, 2023 · Past); Globeimmune Inc (Director · Jul 1, 2014 – Mar 18, 2016 · Past); Cardiovascular Systems Inc (Director · Aug 31, 2012 – Apr 27, 2023 · Past); Human Genome Sciences Inc (Director · Oct 10, 2011 – Jul 30, 2012 · Past) | Chief Operating Officer · Since at least Jan 20, 2017 |
| Amanda Fabiano Other companies: Nakamoto Inc. (Chief Operating Officer · Since at least Aug 6, 2025); TeraWulf Inc. (Director · Since at least Jan 12, 2024) | Director · Since at least Sep 21, 2026 |
| Thomas John Dietz Other companies: Eiger Biopharmaceuticals Inc (Director · Mar 14, 2018 – Mar 1, 2023 · Past); Paratek Pharmaceuticals Inc (Director · Feb 5, 2018 – Sep 21, 2023 · Past) | Director · Since at least Apr 18, 2018 |
| Cynthia Sirard Other companies: Compass Therapeutics, Inc. (Chief Medical Officer · Since at least Jan 2, 2026) | Chief Medical Officer · Apr 1, 2020 – Mar 28, 2025 · Past |
| Joseph Loscalzo Other companies: Ionis Pharmaceuticals, Inc. (Director · Since at least Jul 1, 2024) | Director · Since at least Jan 29, 2024 |
| Nissim Mashiach Other companies: Omrix Biopharmaceuticals Inc (President and COO · Dec 30, 2005 – Oct 10, 2008 · Past) | Director · Since at least Jan 23, 2017 |
| Patricia Martin Other companies: AN2 Therapeutics, Inc. (Director · Since at least May 12, 2022) | Director · Since at least Jan 17, 2023 |
| Christian M Richard | Director · Since at least Jan 17, 2023 |
| Christine Granfield | VP, Head of Reg Affairs/Qual · Sep 1, 2022 – Mar 28, 2025 · Past |
| Christopher Mirabelli | Director · Since at least Jan 26, 2024 |
| Douglas E Onsi | CEO,CFO,Pres.,GC,Treas.&Sec., Director · Since at least Jun 11, 2019 |
| Jason Baum | Chief Scientific Officer · Since at least Jan 29, 2024 |
| John Mark O'Mahony | Chief Manufacturing Officer · Since at least Apr 1, 2020 |
| John W Littlechild | Director · Jan 20, 2017 – Mar 2, 2020 · Past |
| Kevin Zhang | Head of Mining, bringing more than a decade of experience · Since at least Aug 18, 2026 |
| Khing Oei | Chairman of the Board · Since at least Nov 12, 2025 |
| Leap Therapeutics | President & Chief Executive Officer · Since at least Aug 12, 2026 |
| Richard Schilsky | Director · Since at least Sep 1, 2022 |
| William Li | Director · Since at least Jan 4, 2021 |
| William Patrick McEvoy | Chief Investment Officer · Since at least Oct 14, 2026 |
| William Patrick McEvoy III | Chief Investment Officer, Director · Since at least Nov 11, 2025 |